Search

3 result(s) for 'author#Jon-David Schwalm' within BMC

1. Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018

   Guidelines recommend both acetylsalicylic acid and ticagrelor following acute coronary syndrome (ACS), but appropriate prescription practices lag. We analyzed the impact of government medication approval, nati...

   Authors: Saurabh Gupta, Emilie P. Belley-Cote, Adam Eqbal, Charlotte McEwen, Ameen Basha, Nicole Wu, Joshua O. Cerasuolo, Shamir Mehta, Jon-David Schwalm and Richard P. Whitlock

   Citation: Implementation Science 2021 16:42

   Content type: Research Published on: 21 April 2021

   • View Full Text
   • View PDF

2. Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): Protocol for a pragmatic, cluster-randomized controlled trial

   Despite evidence-based recommendations supporting long-term use of cardiac medications in patients post ST-elevation myocardial infarction, adherence is known to decline over time. Discontinuation of cardiac m...

   Authors: Noah M Ivers, Jon-David Schwalm, Jeremy M Grimshaw, Holly Witteman, Monica Taljaard, Merrick Zwarenstein and Madhu K Natarajan

   Citation: Implementation Science 2012 7:54

   Content type: Study protocol Published on: 9 June 2012

   • View Full Text
   • View PDF

3. Could patents interfere with the development of a cardiovascular polypill?

   The Wellcome Trust, the World Health Organization, and cardiologists have advocated for the idea of a “polypill” containing multiple cardiovascular drugs to be co-formulated into a single pill for over a decad...

   Authors: Reed F. Beall, Jon-David R. Schwalm, Mark D. Huffman, Tara McCready, Salim Yusuf and Amir Attaran

   Citation: Journal of Translational Medicine 2016 14:242

   Content type: Research Published on: 18 August 2016

   • View Full Text
   • View PDF